Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Trial details
- Registry ID
- NCT07284459
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as PIPE-791
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary FibrosisNCT07284459 | Contineum Therapeutics | Phase 2 | Recruiting | 2028-05Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |